ASX - By Stock
|
MSB |
Re:
Market opportunity aGVHD
|
|
Broderick
|
74 |
33K |
8 |
11/08/18 |
11/08/18 |
ASX - By Stock
|
74
|
33K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
Broderick
|
3.4K |
1.3M |
8 |
27/07/18 |
27/07/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Enters Into Cardiovascular Alliance For China With Tasly
|
|
Broderick
|
292 |
125K |
1 |
22/07/18 |
22/07/18 |
ASX - By Stock
|
292
|
125K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Enters Into Cardiovascular Alliance For China With Tasly
|
|
Broderick
|
292 |
125K |
2 |
22/07/18 |
22/07/18 |
ASX - By Stock
|
292
|
125K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Market opportunity aGVHD
|
|
Broderick
|
74 |
33K |
2 |
17/07/18 |
17/07/18 |
ASX - By Stock
|
74
|
33K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Market opportunity aGVHD
|
|
Broderick
|
74 |
33K |
0 |
14/07/18 |
14/07/18 |
ASX - By Stock
|
74
|
33K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Market opportunity aGVHD
|
|
Broderick
|
74 |
33K |
6 |
14/07/18 |
14/07/18 |
ASX - By Stock
|
74
|
33K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Market opportunity aGVHD
|
|
Broderick
|
74 |
33K |
2 |
14/07/18 |
14/07/18 |
ASX - By Stock
|
74
|
33K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Director Appointment/Resignation
|
|
Broderick
|
37 |
17K |
4 |
20/06/18 |
20/06/18 |
ASX - By Stock
|
37
|
17K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
AGVHD 100 day survival.
|
|
Broderick
|
75 |
42K |
8 |
13/06/18 |
13/06/18 |
ASX - By Stock
|
75
|
42K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
H.C. Wainwright / MESO - Initiating With Buy
|
|
Broderick
|
7 |
6.0K |
1 |
11/06/18 |
11/06/18 |
ASX - By Stock
|
7
|
6.0K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
Broderick
|
3.4K |
1.3M |
2 |
09/06/18 |
09/06/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
Broderick
|
3.4K |
1.3M |
3 |
09/06/18 |
09/06/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Surely a takeover target
|
|
Broderick
|
10 |
7.0K |
2 |
08/06/18 |
08/06/18 |
ASX - By Stock
|
10
|
7.0K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Are we there yet? Are we there yet? Are we there yet....
|
|
Broderick
|
15 |
5.8K |
0 |
06/06/18 |
06/06/18 |
ASX - By Stock
|
15
|
5.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Are we there yet? Are we there yet? Are we there yet....
|
|
Broderick
|
15 |
5.8K |
0 |
06/06/18 |
06/06/18 |
ASX - By Stock
|
15
|
5.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Partnership For Allogeneic Cell-based Cancer Immunotherapies
|
|
Broderick
|
34 |
14K |
3 |
31/05/18 |
31/05/18 |
ASX - By Stock
|
34
|
14K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Partnership For Allogeneic Cell-based Cancer Immunotherapies
|
|
Broderick
|
34 |
14K |
2 |
31/05/18 |
31/05/18 |
ASX - By Stock
|
34
|
14K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB chart
|
|
Broderick
|
951 |
308K |
1 |
22/05/18 |
22/05/18 |
ASX - By Stock
|
951
|
308K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB chart
|
|
Broderick
|
951 |
308K |
7 |
20/05/18 |
20/05/18 |
ASX - By Stock
|
951
|
308K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
Broderick
|
190 |
69K |
4 |
09/05/18 |
09/05/18 |
ASX - By Stock
|
190
|
69K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Silvui on Bloomberg
|
|
Broderick
|
24 |
11K |
10 |
28/04/18 |
28/04/18 |
ASX - By Stock
|
24
|
11K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Clinical Program Update For MPC-150-IM In Heart Failure
|
|
Broderick
|
116 |
45K |
0 |
19/04/18 |
19/04/18 |
ASX - By Stock
|
116
|
45K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Licensees and MSCs
|
|
Broderick
|
12 |
8.0K |
1 |
18/04/18 |
18/04/18 |
ASX - By Stock
|
12
|
8.0K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Broderick
|
17K |
6.7M |
2 |
24/02/18 |
24/02/18 |
ASX - By Stock
|
17K
|
6.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Upcoming Milestones over remainder of 2018
|
|
Broderick
|
28 |
9.8K |
0 |
22/02/18 |
22/02/18 |
ASX - By Stock
|
28
|
9.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Upcoming Milestones over remainder of 2018
|
|
Broderick
|
28 |
9.8K |
1 |
21/02/18 |
21/02/18 |
ASX - By Stock
|
28
|
9.8K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Upcoming Milestones over remainder of 2018
|
|
Broderick
|
28 |
9.8K |
1 |
21/02/18 |
21/02/18 |
ASX - By Stock
|
28
|
9.8K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Upcoming Milestones over remainder of 2018
|
|
Broderick
|
28 |
9.8K |
9 |
20/02/18 |
20/02/18 |
ASX - By Stock
|
28
|
9.8K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Another shakeout before move up?
|
|
Broderick
|
155 |
68K |
1 |
13/02/18 |
13/02/18 |
ASX - By Stock
|
155
|
68K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Another shakeout before move up?
|
|
Broderick
|
155 |
68K |
1 |
12/02/18 |
12/02/18 |
ASX - By Stock
|
155
|
68K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Another shakeout before move up?
|
|
Broderick
|
155 |
68K |
3 |
12/02/18 |
12/02/18 |
ASX - By Stock
|
155
|
68K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
FDA DISCUSSION
|
|
Broderick
|
26 |
14K |
9 |
03/02/18 |
03/02/18 |
ASX - By Stock
|
26
|
14K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast has turned a corner
|
|
Broderick
|
840 |
218K |
1 |
28/01/18 |
28/01/18 |
ASX - By Stock
|
840
|
218K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
FDA DISCUSSION
|
|
Broderick
|
26 |
14K |
2 |
25/01/18 |
25/01/18 |
ASX - By Stock
|
26
|
14K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Phase 2 Trial Results Show Early and Durable Effects of Single Mesenchymal Precursor Cell
|
|
Broderick
|
278 |
60K |
1 |
11/11/17 |
11/11/17 |
ASX - By Stock
|
278
|
60K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Phase 2 Trial Results Show Early and Durable Effects of Single Mesenchymal Precursor Cell
|
|
Broderick
|
278 |
60K |
0 |
11/11/17 |
11/11/17 |
ASX - By Stock
|
278
|
60K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB chart
|
|
Broderick
|
951 |
308K |
4 |
10/11/17 |
10/11/17 |
ASX - By Stock
|
951
|
308K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Back pain stem cell injection
|
|
Broderick
|
136 |
39K |
1 |
07/11/17 |
07/11/17 |
ASX - By Stock
|
136
|
39K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Broderick
|
17K |
6.7M |
6 |
21/10/17 |
21/10/17 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Broderick
|
17K |
6.7M |
4 |
21/10/17 |
21/10/17 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB chart
|
|
Broderick
|
951 |
308K |
2 |
17/10/17 |
17/10/17 |
ASX - By Stock
|
951
|
308K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB chart
|
|
Broderick
|
951 |
308K |
2 |
16/10/17 |
16/10/17 |
ASX - By Stock
|
951
|
308K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: End-Stage Heart Failure Trial Completes Enrollment
|
|
Broderick
|
131 |
48K |
0 |
28/09/17 |
28/09/17 |
ASX - By Stock
|
131
|
48K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MNK negotiations....
|
|
Broderick
|
135 |
41K |
4 |
21/09/17 |
21/09/17 |
ASX - By Stock
|
135
|
41K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MNK negotiations....
|
|
Broderick
|
135 |
41K |
4 |
20/09/17 |
20/09/17 |
ASX - By Stock
|
135
|
41K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MNK negotiations....
|
|
Broderick
|
135 |
41K |
1 |
20/09/17 |
20/09/17 |
ASX - By Stock
|
135
|
41K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
RA trial results?
|
|
Broderick
|
6 |
2.0K |
1 |
20/09/17 |
20/09/17 |
ASX - By Stock
|
6
|
2.0K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Reports on Annual and Fourth Quarter Results
|
|
Broderick
|
69 |
27K |
1 |
31/08/17 |
31/08/17 |
ASX - By Stock
|
69
|
27K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Reports on Annual and Fourth Quarter Results
|
|
Broderick
|
69 |
27K |
2 |
30/08/17 |
30/08/17 |
ASX - By Stock
|
69
|
27K
|
2
|
|